IBC - Institutional Biosafety Committee


ibcThe Institutional Biosafety Committee (IBC) is the cornerstone of oversight for research involving recombinant and synthetic nucleic acid molecules.


The IBC reviews, approves, and oversees research involving the use of recombinant or synthetic DNA/RNA and other biohazards. This included funded and non-funded research and or teaching.


Training

The "Biosafety Training Course" provides training for researchers handling biohazards in a research or clinical laboratory. The course addresses awareness of biohazards, risk assessment, key risk management principals, personal protective equipment, engineering controls and emergency response.

The IBC will be requiring protocol and lab approval for conducting experiments with various biohazards. Training must be completed prior to submission.

IBC Training

IBC Information

 The IBC will need to review projects involving hazardous biological materials, including:

  • Recombinant DNA (as defined by the NIH Guidelines and including transgenic animals and plants)
  • Select agents (defined by 42 CFR Part 73, 9 CFR Part 121, and 7 CFR Part 331)
  • All RG-2 or greater human or zoonotic pathogens
  • Strict animal and plant pathogens that are either reportable or non-indigenous to Texas

Additional IBC Information
The NIH Guidelines for Research Involving Recombinant or Synthetic Nucleic Acid Molecules detail safety practices and containment procedures for basic and clinical research involving recombinant or synthetic nucleic acid molecules, including the creation and use of organisms and viruses containing recombinant or synthetic nucleic acid molecules.